PALBOCICLIB — all Canadian products
15 DINs
12 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is PALBOCICLIB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02493535 | IBRANCE | PFIZER CANADA ULC | Tablet | Oral | PALBOCICLIB 75 MG | Marketed | |
| 02493551 | IBRANCE | PFIZER CANADA ULC | Tablet | Oral | PALBOCICLIB 125 MG | Marketed | |
| 02493543 | IBRANCE | PFIZER CANADA ULC | Tablet | Oral | PALBOCICLIB 100 MG | Marketed | |
| 02570149 | NAT-PALBOCICLIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | PALBOCICLIB 100 MG | Approved | |
| 02570157 | NAT-PALBOCICLIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | PALBOCICLIB 125 MG | Approved | |
| 02570130 | NAT-PALBOCICLIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | PALBOCICLIB 75 MG | Approved | |
| 02552124 | PMS-PALBOCICLIB | PHARMASCIENCE INC | Tablet | Oral | PALBOCICLIB 75 MG | Marketed | |
| 02552140 | PMS-PALBOCICLIB | PHARMASCIENCE INC | Tablet | Oral | PALBOCICLIB 125 MG | Marketed | |
| 02552132 | PMS-PALBOCICLIB | PHARMASCIENCE INC | Tablet | Oral | PALBOCICLIB 100 MG | Marketed | |
| 02547643 | TARO-PALBOCICLIB | TARO PHARMACEUTICALS INC | Tablet | Oral | PALBOCICLIB 100 MG | Marketed | |
| 02547635 | TARO-PALBOCICLIB | TARO PHARMACEUTICALS INC | Tablet | Oral | PALBOCICLIB 75 MG | Marketed | |
| 02547651 | TARO-PALBOCICLIB | TARO PHARMACEUTICALS INC | Tablet | Oral | PALBOCICLIB 125 MG | Marketed | |
| 02453150 | IBRANCE | PFIZER CANADA ULC | Capsule | Oral | PALBOCICLIB 75 MG | Cancelled Post Market | |
| 02453177 | IBRANCE | PFIZER CANADA ULC | Capsule | Oral | PALBOCICLIB 125 MG | Cancelled Post Market | |
| 02453169 | IBRANCE | PFIZER CANADA ULC | Capsule | Oral | PALBOCICLIB 100 MG | Cancelled Post Market |
Browse other molecules: